4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-25-004708
Chief Executive Officer acquired 9,550 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2025-02-07 | Grant or award | +9,550 | $20.10 | $191,955 | 3,773,802 | D |
Loading xslF345X05/wk-form4_1739229790.xml…